NCT03442465 Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas Status RECRUITING Phase N/A
NCT03436654 Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03435380 Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer Status COMPLETED Phase NA
NCT03434730 Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation Status COMPLETED Phase PHASE2
NCT03434678 Use of Epidurals Intraoperatively for Patients Undergoing Pancreas Resection Status COMPLETED Phase PHASE3
NCT03432806 A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03430908 Blind Gastric Tube Placement: Incidence of Malposition Confirmed by Ultrasonography Status COMPLETED Phase N/A
NCT03430895 Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary Tract Status COMPLETED Phase PHASE2
NCT03424915 Exercise, Fitness and Tumor Profiling in Breast Cancer Patients Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03420508 Treating Patients With Melanoma and ALK Alterations With Ensartinib Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03414229 A Study of Epacadostat, an IDO1 Inhibitor, in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03410875 A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03408366 A Study Assessing Circulation Around Surgical Incisions at the Time of Laparotomy Closure Status COMPLETED Phase NA
NCT03399552 Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma Status COMPLETED Phase PHASE1/PHASE2
NCT03396341 Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes Status RECRUITING Phase N/A
NCT03377387 Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03372902 Development Of A Blood Test To Improve The Performance Of Breast Cancer Screening Status COMPLETED Phase N/A